Federal Awards · MAPP BIOPHARMACEUTICAL, INC. · Award

HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS

Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.

Award details

Award ID
HT942525FE048
Awarding agency
Department of Defense
Sub-agency / office
Defense Health Agency
Award amount
$60,500
Period of performance
Sep 19, 2025 – Feb 25, 2026
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
PSC
PSC 6550
Place of performance
SAN DIEGO, CA, 921213823, USA
Competition
NOT COMPETED UNDER SAP
Pricing
FIRM FIXED PRICE
Financial breakdown
Current value $60,500 · Obligated $60,500 · Potential value $60,500 · Latest action obligation $60,500
Parent award
HT942525D0009

Public award description

Limited purpose

HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS

Most recent · Modification 0 · Sep 16, 2025 · $60,500 action obligation · HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS · HT942525FE048

Source: USAspending.gov

Find out who's winning similar federal contracts

Discover comparable awards, related contractors, and agency purchasing history.

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

SmartSoloChatGPTClaudePerplexityGrokGemini

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.